Therapeutic potential of antagomiRs in haematological and oncological neoplasms.
Vanessa InnaoAlessandro AllegraNicolina PulvirentiAndrea Gaetano AllegraCaterina MusolinoPublished in: European journal of cancer care (2020)
They are ambitious but fascinating promise to alter the promotion of the tumour growth by binding specific molecular targets, with high precision and low toxicity, leaving the scientists the chance of development as anti-cancer drugs and not just.